30 Years of Evidence
Join the experts’ corner
This page presents publications and webinars from around the globe. It includes evidence for a wide range of treatment sites including malignant and benign disease, different fractionation schedules and motion synchronization techniques for both the CyberKnife® and TomoTherapy® platforms. We update new papers on a regular basis. Please take a moment to explore the page and see the evidence we have collected to truly demonstrate how we are making a change to peoples’ lives.
Featured Content
ESTRO 2024
SBRT Focal Boost for Localised Prostate Cancer: Primary Outcomes of the SPARC Prospective Trial
Date: 2024
Treatment Technique: SBRT
Platform: CyberKnife System
Author: Binnaz Yasar et al.
ESTRO 2024
Efficacy and Toxicity of Moderately Hypofractionated Radiotherapy via Helical TomoTherapy versus Conventional Radiotherapy Combined with Concurrent Chemotherapy for Patients with Unresectable
Stage III NSCLC
Date: 2024
Treatment Technique: IG-IMRT
Platform: TomoTherapy System
Author: Huang Wenhan et al.
ESTRO 2024
Feasibility of SBRT with CyberKnife in the Scenario of Lung Metastases Re-RT: Monoinstitutional Experience
Date: 2024
Treatment Technique: SBRT
Platform: CyberKnife System
Author: Esmeralda Scipilliti et al.
Breast Cancer: Your Challenges Today – Our Solutions for Tomorrow
Nathan Corradini, Jennifer R. Bellon
Hypofractionated postmastectomy radiotherapy with helical tomotherapy in patients with immediate breast reconstruction: dosimetric results and acute/intermediate toxicity evaluation
Orecchia R, Rojas DP, Cattani F, Ricotti R, Santoro L, Morra A, Cambria R, Luraschi R, Dicuonzo S, Ronchi S, Surgo A, Dell’ Acqua V, Veronesi P, De Lorenzi F, Fodor C, Leonardi MC, Jereczek-Fossa BA | Med Oncol | 2018
Use of helical tomotherapy in locally advanced and/or metastatic breast cancer for locoregional treatment
Thery L, Arsene-Henry A, Carroll S, Peurien D, Bazire L, Robilliard M, Fourquet A, Kirova YM | Br J Radiol | 2018
The use of helical tomotherapy in the treatment of early stage breast cancer: indications, tolerance, efficacy-a single center experience
Arsene-Henry A, Foy JP, Robilliard M, Xu HP, Bazire L, Peurien D, Poortmans P, Fourquet A, Kirova YM | Oncotarget | 2018
Clinical outcomes and dosimetric study of hypofractionated Helical TomoTherapy in breast cancer patients
Chitapanarux I, Nobnop W, Tippanya D, Sripan P, Chakrabandhu S, Klunklin P, Onchan W, Jia-Mahasap B, Tharavichitkul E | PLoS One | 2019
Cardiac Sparing with Personalized Treatment Planning for Early-stage Left Breast Cancer
Mathieu D, Bedwani S, Mascolo-Fortin J, Côté N, Bernard AA, Roberge D, Yassa M, Bahig H, Vu T | Cureus | 2020